2D and 3D QSAR
METAPHORICAL QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP (2D & 3D QSAR) ANALYSIS OF TYLOPHORINE DERIVATIVES AS EFFICACIOUS IN ANTIMALARIAL DRUG DESIGN
14
2D and 3D QSAR of Benzimidazole Analogues as Novel HIV-1 Non Nucleoside Reverse Transcriptase Inhibitors
7
2D and 3D QSAR Studies of Saponin Analogues as Antifungal Agents against Candida albicans
7
Accessing the Anti-Proliferating Activity of Tankyrase-2 Inhibitors via 2D, 3D-QSAR and Molecular Docking: Assessment of Structure Activity Relationships
14
2D & 3D QSAR STUDIES OF BIARYL ANALOGUES OF PA-824 HAVING VARIOUS ETHER LINKERS: AN APPROACH TO DESIGN ANTITUBERCULAR AGENTS
13
2D and 3D QSAR Analysis of some 1, 3 disubstituted Urea Derivatives for Antiproliferative Activity
9
2D AND 3D QSAR STUDIES OF INDOLIZINO [6, 7-B] INDOLE DERIVATIVES AS TOPOISOMERASE I AND II DUAL INHIBITORS
10
2D and 3D QSAR Analysis of some novel 2 {[2 (1H imidazol 1 yl)ethyl]sulfanyl} 1H benzimidazole derivatives
6
← Return to Article Details A 2D/3D-QSAR STUDY ON BIOLOGICAL ACTIVITIES OF 1,2-ETHYLENDIAMINE DERIVATIVES AS ANTI-TUBERCULOSIS DRUGS
5
Comparative qsar analysis of histone deacetylase 6 (hdac6) inhibitors as anti cancer agents
6
2D & 3D QSAR AND DRUG DESIGNING OF PHENOTHIAZINE DERIVATIVES AS POTENT ANTITUBERCULAR AGENTS
40
Hologram quantitative structure–activity relationship and comparative molecular field analysis studies within a series of tricyclic phthalimide HIV-1 integrase inhibitors
9
2D QSAR of arylpiperazines as 5-HT1A receptor agonists
6
3D QSAR ANALYSIS ON OXADIAZOLE DERIVATIVES AS ANTICANCER AGENTS
6
Quantitative structure activity relationship analysis of some 2 substituted halogenbenzimidazoles analogues using computer aided drug designing technique
9
2D QSAR ANALYSIS OF PHTHALIMIDE DERIVATIVES AS POTENT HYPOGLYCEMIC AGENTS
7
Automatic generation of alignments for 3D QSAR analyses
21
2D to 3D Video COnversion
9
2D QSAR Study of Indole Derivatives for Anti Microbial Study
8
3d qsar and molecular docking studies on anilino pyrimidine and anilino quinazolines as kinase inhibitors
6